 Andrew Subudhi
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebrovascular Circulation | 23 | 2017 | 216 | 4.550 |
Why?
| | Altitude Sickness | 21 | 2020 | 137 | 3.920 |
Why?
| | Hypoxia | 30 | 2024 | 1034 | 3.590 |
Why?
| | Altitude | 30 | 2023 | 451 | 3.370 |
Why?
| | Acclimatization | 20 | 2023 | 160 | 2.800 |
Why?
| | Oxygen Consumption | 20 | 2024 | 669 | 2.270 |
Why?
| | Oxygen | 20 | 2023 | 899 | 2.080 |
Why?
| | Exercise | 23 | 2024 | 1917 | 2.010 |
Why?
| | Homeostasis | 7 | 2017 | 605 | 1.600 |
Why?
| | Middle Cerebral Artery | 7 | 2015 | 42 | 1.600 |
Why?
| | Blood Flow Velocity | 13 | 2017 | 404 | 1.200 |
Why?
| | Brain | 8 | 2016 | 2615 | 0.830 |
Why?
| | Carbon Dioxide | 10 | 2015 | 258 | 0.740 |
Why?
| | Methazolamide | 1 | 2020 | 4 | 0.690 |
Why?
| | Arterial Pressure | 3 | 2016 | 116 | 0.690 |
Why?
| | Theophylline | 1 | 2020 | 64 | 0.680 |
Why?
| | Antioxidants | 6 | 2013 | 542 | 0.650 |
Why?
| | Quadriceps Muscle | 4 | 2023 | 128 | 0.650 |
Why?
| | Muscle Fatigue | 6 | 2014 | 101 | 0.650 |
Why?
| | Acute Disease | 9 | 2020 | 961 | 0.570 |
Why?
| | Physical Endurance | 7 | 2020 | 262 | 0.570 |
Why?
| | Posture | 2 | 2017 | 176 | 0.560 |
Why?
| | Bicycling | 10 | 2011 | 116 | 0.530 |
Why?
| | Cross-Over Studies | 8 | 2020 | 507 | 0.480 |
Why?
| | Exercise Test | 8 | 2024 | 613 | 0.480 |
Why?
| | Young Adult | 24 | 2019 | 12281 | 0.480 |
Why?
| | Adult | 44 | 2024 | 35176 | 0.470 |
Why?
| | Muscle Contraction | 2 | 2007 | 423 | 0.450 |
Why?
| | Spectroscopy, Near-Infrared | 7 | 2020 | 48 | 0.440 |
Why?
| | Regional Blood Flow | 4 | 2013 | 457 | 0.430 |
Why?
| | Radial Artery | 2 | 2013 | 69 | 0.420 |
Why?
| | Ultrasonography, Doppler, Transcranial | 7 | 2013 | 37 | 0.410 |
Why?
| | Oxidative Stress | 6 | 2018 | 1181 | 0.390 |
Why?
| | Acetazolamide | 2 | 2011 | 24 | 0.390 |
Why?
| | Athletic Performance | 2 | 2012 | 75 | 0.390 |
Why?
| | Hypoxia, Brain | 2 | 2011 | 8 | 0.380 |
Why?
| | Male | 45 | 2024 | 62757 | 0.380 |
Why?
| | Erythrocytes | 4 | 2017 | 673 | 0.360 |
Why?
| | Hyperoxia | 2 | 2010 | 87 | 0.350 |
Why?
| | Blood Pressure | 4 | 2017 | 1711 | 0.340 |
Why?
| | Double-Blind Method | 9 | 2020 | 1852 | 0.340 |
Why?
| | Atmospheric Pressure | 1 | 2010 | 15 | 0.340 |
Why?
| | Humans | 63 | 2024 | 128019 | 0.340 |
Why?
| | Hemoglobins | 4 | 2014 | 336 | 0.340 |
Why?
| | Dexamethasone | 2 | 2011 | 339 | 0.330 |
Why?
| | Pulmonary Gas Exchange | 4 | 2019 | 118 | 0.310 |
Why?
| | Pulmonary Ventilation | 4 | 2013 | 77 | 0.300 |
Why?
| | Motor Cortex | 1 | 2009 | 58 | 0.300 |
Why?
| | Competitive Behavior | 1 | 2008 | 41 | 0.290 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 63 | 0.280 |
Why?
| | Physical Exertion | 2 | 2007 | 207 | 0.280 |
Why?
| | Muscle, Skeletal | 7 | 2023 | 1619 | 0.270 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 32 | 0.270 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 8 | 0.270 |
Why?
| | Frontal Lobe | 1 | 2007 | 153 | 0.260 |
Why?
| | Prefrontal Cortex | 1 | 2009 | 299 | 0.250 |
Why?
| | Female | 26 | 2024 | 68016 | 0.240 |
Why?
| | Respiration | 5 | 2012 | 190 | 0.240 |
Why?
| | Ventricular Function, Right | 2 | 2024 | 274 | 0.230 |
Why?
| | Models, Cardiovascular | 3 | 2011 | 190 | 0.230 |
Why?
| | Adaptation, Physiological | 3 | 2016 | 513 | 0.220 |
Why?
| | Cerebral Cortex | 1 | 2007 | 422 | 0.220 |
Why?
| | Sports | 3 | 2012 | 221 | 0.210 |
Why?
| | Single-Blind Method | 5 | 2012 | 267 | 0.200 |
Why?
| | Blood Gas Analysis | 5 | 2015 | 71 | 0.200 |
Why?
| | Vertebral Artery | 2 | 2012 | 25 | 0.200 |
Why?
| | Carotid Artery, Internal | 2 | 2012 | 41 | 0.200 |
Why?
| | Anaerobic Threshold | 3 | 2009 | 28 | 0.190 |
Why?
| | Rest | 4 | 2015 | 120 | 0.190 |
Why?
| | Heart Rate | 5 | 2014 | 797 | 0.180 |
Why?
| | Skiing | 1 | 2001 | 44 | 0.170 |
Why?
| | Time Factors | 9 | 2016 | 6479 | 0.170 |
Why?
| | Proteomics | 2 | 2018 | 1008 | 0.160 |
Why?
| | Energy Metabolism | 3 | 2018 | 831 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 212 | 0.150 |
Why?
| | Metabolome | 2 | 2018 | 319 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 13 | 0.140 |
Why?
| | Inhalation | 2 | 2007 | 28 | 0.130 |
Why?
| | Sphingosine | 1 | 2016 | 36 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2016 | 68 | 0.130 |
Why?
| | Syncope | 1 | 2016 | 50 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2016 | 194 | 0.120 |
Why?
| | Foramen Ovale, Patent | 1 | 2015 | 14 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2016 | 189 | 0.120 |
Why?
| | Severity of Illness Index | 3 | 2013 | 2703 | 0.120 |
Why?
| | Erythropoiesis | 1 | 2014 | 51 | 0.110 |
Why?
| | Tibet | 1 | 2014 | 27 | 0.110 |
Why?
| | Peru | 1 | 2014 | 53 | 0.110 |
Why?
| | Bolivia | 1 | 2014 | 63 | 0.110 |
Why?
| | Glutathione | 3 | 2016 | 340 | 0.110 |
Why?
| | Mountaineering | 2 | 2011 | 34 | 0.110 |
Why?
| | Surveys and Questionnaires | 5 | 2013 | 5353 | 0.100 |
Why?
| | Lipid Peroxidation | 2 | 2004 | 147 | 0.100 |
Why?
| | Carotid Artery, External | 1 | 2012 | 3 | 0.100 |
Why?
| | Healthy Volunteers | 3 | 2018 | 199 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1747 | 0.100 |
Why?
| | Analysis of Variance | 4 | 2010 | 1266 | 0.100 |
Why?
| | Malondialdehyde | 2 | 2009 | 28 | 0.100 |
Why?
| | Motor Activity | 2 | 2014 | 667 | 0.100 |
Why?
| | Skull | 1 | 2012 | 128 | 0.090 |
Why?
| | Blood Proteins | 1 | 2013 | 239 | 0.090 |
Why?
| | Pulse Wave Analysis | 1 | 2012 | 246 | 0.090 |
Why?
| | Vasoconstriction | 1 | 2012 | 185 | 0.090 |
Why?
| | Pulmonary Edema | 2 | 2010 | 104 | 0.090 |
Why?
| | Body Temperature Regulation | 1 | 2012 | 95 | 0.090 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 80 | 0.090 |
Why?
| | Cold Temperature | 1 | 2012 | 153 | 0.090 |
Why?
| | Glycolysis | 3 | 2018 | 293 | 0.090 |
Why?
| | Lactic Acid | 3 | 2009 | 294 | 0.090 |
Why?
| | Cerebral Arteries | 1 | 2011 | 57 | 0.090 |
Why?
| | Forecasting | 1 | 2012 | 355 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2018 | 1001 | 0.080 |
Why?
| | Running | 1 | 2012 | 222 | 0.080 |
Why?
| | Hot Temperature | 1 | 2012 | 359 | 0.080 |
Why?
| | Fourier Analysis | 1 | 2009 | 39 | 0.080 |
Why?
| | Vasodilation | 1 | 2012 | 461 | 0.080 |
Why?
| | Ribose | 1 | 2009 | 21 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2012 | 324 | 0.080 |
Why?
| | Manometry | 1 | 2009 | 90 | 0.080 |
Why?
| | Reaction Time | 1 | 2011 | 406 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2011 | 199 | 0.080 |
Why?
| | Algorithms | 3 | 2014 | 1609 | 0.080 |
Why?
| | Heart Ventricles | 2 | 2024 | 765 | 0.080 |
Why?
| | Phosphorylation | 3 | 2018 | 1681 | 0.080 |
Why?
| | Exhalation | 1 | 2007 | 38 | 0.070 |
Why?
| | Oxyhemoglobins | 1 | 2007 | 21 | 0.070 |
Why?
| | Pentose Phosphate Pathway | 2 | 2018 | 49 | 0.070 |
Why?
| | Nutritional Requirements | 1 | 2007 | 77 | 0.070 |
Why?
| | Blood Volume | 1 | 2007 | 59 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 37 | 0.070 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 67 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1934 | 0.070 |
Why?
| | Sports Medicine | 1 | 2008 | 108 | 0.060 |
Why?
| | Cognition | 1 | 2014 | 1104 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 488 | 0.060 |
Why?
| | Drinking | 1 | 2005 | 39 | 0.060 |
Why?
| | Recovery of Function | 1 | 2009 | 630 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2007 | 143 | 0.060 |
Why?
| | Physical Education and Training | 1 | 2004 | 75 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2007 | 3009 | 0.060 |
Why?
| | Lung | 2 | 2015 | 3745 | 0.060 |
Why?
| | Placebos | 1 | 2004 | 201 | 0.060 |
Why?
| | Exercise Tolerance | 1 | 2006 | 271 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2006 | 396 | 0.050 |
Why?
| | Partial Pressure | 2 | 2013 | 29 | 0.050 |
Why?
| | Hypercapnia | 2 | 2013 | 49 | 0.050 |
Why?
| | DNA Damage | 1 | 2004 | 363 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2004 | 580 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5268 | 0.050 |
Why?
| | Adolescent | 3 | 2017 | 20158 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 712 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2014 | 1994 | 0.050 |
Why?
| | Chronic Disease | 1 | 2007 | 1690 | 0.050 |
Why?
| | Colorimetry | 1 | 2001 | 12 | 0.050 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2011 | 14 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1185 | 0.040 |
Why?
| | Tidal Volume | 2 | 2012 | 82 | 0.040 |
Why?
| | Bone Density | 1 | 2004 | 474 | 0.040 |
Why?
| | Brain Edema | 2 | 2011 | 60 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2646 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 2757 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2011 | 10110 | 0.040 |
Why?
| | Dehydration | 2 | 2012 | 49 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Carnitine | 1 | 2018 | 76 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 162 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 342 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Diet | 1 | 2004 | 1198 | 0.030 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 110 | 0.030 |
Why?
| | Muscles | 1 | 2018 | 322 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 98 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 15 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 42 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 50 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 221 | 0.030 |
Why?
| | Animals | 5 | 2017 | 34487 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 131 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 292 | 0.030 |
Why?
| | Purines | 1 | 2016 | 168 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2015 | 45 | 0.030 |
Why?
| | Biomarkers | 3 | 2013 | 3874 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 415 | 0.030 |
Why?
| | Proteins | 1 | 2001 | 933 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 259 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 411 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 796 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 476 | 0.030 |
Why?
| | Heart Sounds | 1 | 2014 | 2 | 0.030 |
Why?
| | Heart Auscultation | 1 | 2014 | 3 | 0.030 |
Why?
| | Acid-Base Equilibrium | 1 | 2013 | 27 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 451 | 0.030 |
Why?
| | Markov Chains | 1 | 2014 | 116 | 0.030 |
Why?
| | Chemoreceptor Cells | 1 | 2013 | 53 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 264 | 0.030 |
Why?
| | Enzymes | 1 | 2013 | 64 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 144 | 0.030 |
Why?
| | Risk Factors | 3 | 2012 | 9696 | 0.030 |
Why?
| | Cold Climate | 1 | 2012 | 8 | 0.020 |
Why?
| | Validation Studies as Topic | 1 | 2012 | 21 | 0.020 |
Why?
| | Hypocapnia | 1 | 2012 | 8 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 541 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2014 | 333 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2013 | 3324 | 0.020 |
Why?
| | Frostbite | 1 | 2012 | 20 | 0.020 |
Why?
| | Hypothermia | 1 | 2012 | 34 | 0.020 |
Why?
| | Health Facilities | 1 | 2012 | 79 | 0.020 |
Why?
| | Respiration Disorders | 1 | 2012 | 72 | 0.020 |
Why?
| | Heat Stress Disorders | 1 | 2012 | 69 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 644 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 452 | 0.020 |
Why?
| | Blood Circulation Time | 1 | 2010 | 2 | 0.020 |
Why?
| | Constriction | 1 | 2010 | 42 | 0.020 |
Why?
| | Vasomotor System | 1 | 2010 | 43 | 0.020 |
Why?
| | Headache | 1 | 2011 | 137 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 126 | 0.020 |
Why?
| | Mice | 2 | 2017 | 16574 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 607 | 0.020 |
Why?
| | Pulse | 1 | 2009 | 25 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1813 | 0.020 |
Why?
| | Free Radicals | 1 | 2009 | 103 | 0.020 |
Why?
| | Software | 1 | 2014 | 606 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 2009 | 53 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2010 | 141 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 150 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 154 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 467 | 0.020 |
Why?
| | Epinephrine | 1 | 2008 | 140 | 0.020 |
Why?
| | Self Disclosure | 1 | 2007 | 62 | 0.020 |
Why?
| | Norepinephrine | 1 | 2008 | 209 | 0.020 |
Why?
| | Magnetics | 1 | 2007 | 44 | 0.020 |
Why?
| | Dogs | 1 | 2008 | 368 | 0.020 |
Why?
| | Lactates | 1 | 2007 | 83 | 0.020 |
Why?
| | Sleep | 1 | 2012 | 675 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 97 | 0.020 |
Why?
| | Urinalysis | 1 | 2005 | 69 | 0.020 |
Why?
| | Middle Aged | 2 | 2020 | 30812 | 0.020 |
Why?
| | Oximetry | 1 | 2005 | 87 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2009 | 531 | 0.010 |
Why?
| | Models, Biological | 1 | 2012 | 1689 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 2004 | 11 | 0.010 |
Why?
| | Maximal Expiratory Flow Rate | 1 | 2004 | 3 | 0.010 |
Why?
| | Electromyography | 1 | 2007 | 380 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1559 | 0.010 |
Why?
| | Anthropometry | 1 | 2004 | 204 | 0.010 |
Why?
| | Task Performance and Analysis | 1 | 2004 | 173 | 0.010 |
Why?
| | Equipment Design | 1 | 2005 | 515 | 0.010 |
Why?
| | Signal Transduction | 1 | 2017 | 4812 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 766 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 454 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 816 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2004 | 253 | 0.010 |
Why?
| | Body Weight | 1 | 2005 | 930 | 0.010 |
Why?
| | Data Collection | 1 | 2004 | 645 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2541 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1272 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 3936 | 0.010 |
Why?
| | Child | 1 | 2014 | 20636 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7035 | 0.010 |
Why?
| | United States | 1 | 2004 | 13785 | 0.000 |
Why?
|
|
Subudhi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|